Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities

Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities

There is controversy over the usefulness of prostate-specific antigen (PSA) as a prostate cancer (PCa) biomarker. This controversy arises when there are differences in the results of PSA assay modalities. In this study, which aimed to evaluate a proper validation between the two PSA assay modalities...

Full description

Bibliographic Details
Main Authors: Jae Hoon Chung, Minsu Park, Hyun Cho, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong IL Seo, Hyun Moo Lee, Seong Soo Jeon
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Biology
Subjects:
prostate-specific antigen
diagnosis
statistics
Online Access:https://www.mdpi.com/2079-7737/10/4/297

Internet

https://www.mdpi.com/2079-7737/10/4/297

Similar Items